PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $724,048 | -25.0% | 23,600 | -2.1% | 0.02% | -19.0% |
Q2 2023 | $965,687 | +10.6% | 24,100 | +12.6% | 0.02% | -4.5% |
Q1 2023 | $873,334 | +103621.4% | 21,400 | -1.8% | 0.02% | -4.3% |
Q4 2022 | $842 | -99.9% | 21,800 | -0.5% | 0.02% | -32.4% |
Q3 2022 | $1,165,000 | -2.3% | 21,900 | -0.5% | 0.03% | +6.2% |
Q2 2022 | $1,193,000 | -26.9% | 22,000 | +1.4% | 0.03% | -17.9% |
Q1 2022 | $1,633,000 | +25.6% | 21,700 | +0.5% | 0.04% | +34.5% |
Q4 2021 | $1,300,000 | +8.5% | 21,600 | +0.9% | 0.03% | 0.0% |
Q3 2021 | $1,198,000 | -0.8% | 21,400 | +7.5% | 0.03% | 0.0% |
Q2 2021 | $1,208,000 | -13.4% | 19,900 | 0.0% | 0.03% | -19.4% |
Q1 2021 | $1,395,000 | +16.5% | 19,900 | -0.5% | 0.04% | +2.9% |
Q4 2020 | $1,197,000 | +0.6% | 20,000 | +1.0% | 0.04% | -36.4% |
Q3 2020 | $1,190,000 | +98.7% | 19,800 | +73.4% | 0.06% | +52.8% |
Q2 2020 | $599,000 | +55.2% | 11,420 | -0.9% | 0.04% | +28.6% |
Q1 2020 | $386,000 | -40.3% | 11,520 | -19.4% | 0.03% | -12.5% |
Q4 2019 | $647,000 | – | 14,290 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |